Two Sigma Investments
VIVO

Two Sigma Investments’s Meridian Bioscience Inc VIVO Stock Holding History

Two Sigma Investments’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-72,809
Closed -$2.21M – 2974
2022
Q2 		$2.21M Buy
72,809
+33,797
+87% +$914K 0.01% 1147
2022
Q1 		$1.01M Buy
+39,012
New +$928K ﹤0.01% 1694
2021
Q4 		– Sell
-46,072
Closed -$886K – 5092
2021
Q3 		$886K Buy
+46,072
New +$918K ﹤0.01% 2713
2020
Q2 		– Sell
-55,287
Closed -$464K – 3685
2020
Q1 		$464K Sell
55,287
-15,352
-22% -$129K ﹤0.01% 1993
2019
Q4 		$690K Buy
+70,639
New +$663K ﹤0.01% 2533
2019
Q3 		– Sell
-10,058
Closed -$119K – 3897
2019
Q2 		$119K Buy
+10,058
New +$121K ﹤0.01% 3183
2019
Q1 		– Sell
-109,339
Closed -$1.9M – 3578
2018
Q4 		$1.9M Buy
109,339
+71,318
+188% +$1.22M 0.01% 1266
2018
Q3 		$567K Sell
38,021
-100,458
-73% -$1.56M ﹤0.01% 2363
2018
Q2 		$2.2M Buy
138,479
+73,060
+112% +$1.09M 0.01% 1543
2018
Q1 		$929K Sell
65,419
-116,525
-64% -$1.72M ﹤0.01% 2057
2017
Q4 		$2.55M Buy
181,944
+38,650
+27% +$566K 0.01% 1304
2017
Q3 		$2.05M Sell
143,294
-33,174
-19% -$474K 0.01% 1296
2017
Q2 		$2.78M Sell
176,468
-87,251
-33% -$1.26M 0.01% 1205
2017
Q1 		$3.64M Buy
263,719
+136,874
+108% +$1.91M 0.01% 1100
2016
Q4 		$2.25M Buy
126,845
+83,990
+196% +$1.48M 0.01% 1391
2016
Q3 		$827K Sell
42,855
-7,480
-15% -$146K ﹤0.01% 2099
2016
Q2 		$982K Buy
+50,335
New +$987K ﹤0.01% 1760
2016
Q1 		– Sell
-13,354
Closed -$274K – 3209
2015
Q4 		$274K Buy
+13,354
New +$256K ﹤0.01% 2297
2015
Q3 		– Sell
-44,971
Closed -$838K – 2866
2015
Q2 		$838K Sell
44,971
-115,688
-72% -$2.15M ﹤0.01% 1771
2015
Q1 		$3.06M Sell
160,659
-22,104
-12% -$409K 0.01% 945
2014
Q4 		$3.01M Buy
182,763
+150,724
+470% +$2.59M 0.02% 845
2014
Q3 		$567K Buy
+32,039
New +$629K ﹤0.01% 1258

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments's VIVO Position: Q3 2022 in Review

Two Sigma Investments sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 72,809 shares — an estimated $2.21M sold.

Two Sigma Investments first reported a position in VIVO in Q3 2014 and held it in 22 quarters. The position peaked at $3.64M in Q1 2017. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Two Sigma Investments reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Investments sold 72,809 Meridian Bioscience Inc shares in Q3 2022, an estimated $2.21M.
  • Two Sigma Investments first reported a position in Meridian Bioscience Inc in Q3 2014 and held it in 22 quarters.
  • Two Sigma Investments's Meridian Bioscience Inc position peaked at $3.64M in Q1 2017.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.